Titlesort descending Credit Type Event date Cost
Part 1: Evolving Understanding of Pathophysiology and Modern Proposed Framework of Alzheimer’s Disease Enduring $0.00
Part 1: Suspicion, Identification, and Evaluation of Patients Who May Have Early Alzheimer’s Disease Neurobiology Enduring $0.00
Part 2: Current Treatments and Rising Phase 3 Disease-Modifying Therapies Enduring $0.00
Part 2: Importance and Implications of Biomarkers in Diagnosis and Modern Treatment of Alzheimer’s Disease Enduring $0.00
Part 3: Diagnostic and Therapeutic Monitoring Strategies and their Potential Role in the Future of Disease-Modifying Therapy for Alzheimer’s Disease Enduring $0.00
Part 3: Evolving Roles in Alzheimer’s Disease Management: Team-Based Care in the Modern Age of Disease-Modifying Therapy Enduring $0.00
Pay It Forward: Bridging the Gaps Between Payers and Providers to Get the Medication Your Patient Needs When They Need It for Narcolepsy and...
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 Attendance
Enduring $0.00
Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) --... Enduring $0.00
Stronger Together: Leveraging Evidence-Based Patient Collaboration and Treatment Strategies to Streamline Success in Multiple Sclerosis
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Attendance
Enduring $0.00
The Frontline of Alzheimer's Care: Addressing Real Questions from Clinicians in the New Dawn of Disease-Modifying Therapy Enduring $0.00
The Hidden Side of Multiple Sclerosis: Harnessing Key Pathologies to Improve Outcomes Across the Multiple Sclerosis Spectrum Live 05/30/2024 - 8:00am EDT $0.00
The Path of Least Resistance: New Agents and Emerging Strategies for Managing Childhood-Onset and Refractory Epilepsies (Credit Expired) Enduring $0.00
Thinking Through ARIA: A Case-Based Exploration of Recognition, Evaluation, and Reporting of Novel Imaging Events of Alzheimer's Therapeutics
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Attendance
Enduring $0.00
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Closing Module
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 AAPA Category I CME
    • 0.50 Attendance
Enduring $0.00
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Emergency Medicine Module
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 AAPA Category I CME
    • 0.50 Attendance
Enduring $0.00

Pages